Skip to main content


Preeclampsia Laboratory Testing Market Analysis Report 2031 The preeclampsia disease is considered to be the second leading cause in cases of maternal mortality. As per the United States’ Center for Disease Control and Prevention, the prevalence of preeclampsia in the United States is among 1 in every 25 pregnancies. This high number has compelled healthcare institutes and infrastructures in adopting modern and efficient solutions in the global preeclampsia laboratory testing market. This disease can also affect an infant’s health as well as the health of the fetus. The disease also created an increased risk of metabolic as well as cardiovascular disorders in either child or mother, or for both, in the future. Hence, the demand for effective and accurate testing and diagnostic equipment, professionals, and resources in high within the global preeclampsia laboratory testing market.


Comments